Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Gluconapin(1-)
2. Chebi:5411
3. N-(sulfonatooxy)-4-pentenimidothioic Acid Beta-d-glucopyranosyl Ester
4. [(z)-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanylpent-4-enylideneamino] Sulfate
| Molecular Weight | 372.4 g/mol |
|---|---|
| Molecular Formula | C11H18NO9S2- |
| XLogP3 | -0.9 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 7 |
| Exact Mass | 372.04229850 g/mol |
| Monoisotopic Mass | 372.04229850 g/mol |
| Topological Polar Surface Area | 203 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | -1 |
| Complexity | 505 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
14
PharmaCompass offers a list of Gluconapin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Gluconapin manufacturer or Gluconapin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Gluconapin manufacturer or Gluconapin supplier.
PharmaCompass also assists you with knowing the Gluconapin API Price utilized in the formulation of products. Gluconapin API Price is not always fixed or binding as the Gluconapin Price is obtained through a variety of data sources. The Gluconapin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Gluconapin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gluconapin, including repackagers and relabelers. The FDA regulates Gluconapin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gluconapin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Gluconapin supplier is an individual or a company that provides Gluconapin active pharmaceutical ingredient (API) or Gluconapin finished formulations upon request. The Gluconapin suppliers may include Gluconapin API manufacturers, exporters, distributors and traders.
Gluconapin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Gluconapin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Gluconapin GMP manufacturer or Gluconapin GMP API supplier for your needs.
A Gluconapin CoA (Certificate of Analysis) is a formal document that attests to Gluconapin's compliance with Gluconapin specifications and serves as a tool for batch-level quality control.
Gluconapin CoA mostly includes findings from lab analyses of a specific batch. For each Gluconapin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Gluconapin may be tested according to a variety of international standards, such as European Pharmacopoeia (Gluconapin EP), Gluconapin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Gluconapin USP).
